Ashley R Dunn

Title: The Innovative Contributions of Ashley R Dunn

Introduction

Ashley R Dunn is a notable inventor based in North Balwyn, Australia. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant DNA molecules. Her work has implications for medical research and therapeutic applications.

Latest Patents

Ashley holds a patent for recombinant DNA molecules. This invention provides a DNA sequence coding for a mammalian granulocyte macrophage colony stimulating factor (GM-CSF). The patent outlines a method for obtaining this sequence, as well as vectors and hosts that harbor it. The sequence is useful as a probe for identifying related sequences and selecting GM-CSF encoding mRNA from a mixture of mRNAs. Additionally, it serves as a source of GM-CSF DNA for expression in an appropriate expression vector. The GM-CSF protein encoded by this sequence is beneficial for stimulating the production of granulocytes and macrophages from their respective progenitor cells.

Career Highlights

Ashley is currently associated with Research Corporation Technologies, Inc., where she continues to advance her research in biotechnology. Her innovative work has positioned her as a key figure in her field, contributing to the understanding and application of GM-CSF in various medical contexts.

Collaborations

Throughout her career, Ashley has collaborated with esteemed colleagues such as Nicholas Martin Gough and Donald Metcalf. These partnerships have enhanced her research efforts and expanded the impact of her inventions.

Conclusion

Ashley R Dunn's contributions to the field of biotechnology through her patent on recombinant DNA molecules exemplify her innovative spirit and dedication to advancing medical science. Her work continues to influence the development of therapies that harness the power of GM-CSF.